Value of Tumor Growth Rate (TGR) as an Early Predictor of Patients' Outcome in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs): The Greponet StudyShow others and affiliations
2018 (English)In: Neuroendocrinology, ISSN 0028-3835, E-ISSN 1423-0194, Vol. 106, no Supplement: 1, p. 178-178Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2018. Vol. 106, no Supplement: 1, p. 178-178
Keywords [en]
tumor growth rate, response, progression-free survival, follow-up, neuroendocrine tumor, prognosis, tgr, recist, radiology
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:uu:diva-355843DOI: 10.1159/000487699ISI: 000427285300176OAI: oai:DiVA.org:uu-355843DiVA, id: diva2:1232913
Conference
15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, MAR 07-09, 2018, Barcelona, SPAIN
Note
Meeting Abstract: G12
Selected For Oral Presentation
2018-07-132018-07-132019-10-30Bibliographically approved